1
|
Scelsi L, Ghio S, Matrone B, Mannucci L, Klersy C, Valaperta S, Turco A, Greco A, Derosa G, Oltrona Visconti L. Galectin-3 Plasma Levels Are Associated with Risk Profiles in Pulmonary Arterial Hypertension. Diagnostics (Basel) 2020; 10:diagnostics10110857. [PMID: 33105539 PMCID: PMC7690258 DOI: 10.3390/diagnostics10110857] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Revised: 10/16/2020] [Accepted: 10/19/2020] [Indexed: 12/12/2022] Open
Abstract
Galectin-3 is a circulating biomarker of fibrosis whose prognostic role in pulmonary arterial hypertension (PAH) has not been fully explored. We undertook a pilot study to evaluate the relationship between galectin-3 plasma levels and validated risk scores in PAH. The study included 70 PAH patients admitted to a single referral center from June 2016 to June 2018. Patients were stratified according to the REVEAL 2.0 risk score, according to the parameters suggested by the European Society of Cardiology and European Respiratory Society (ESC/ERS) Guidelines, and according to a focused echocardiographic assessment of right heart performance. The association between galectin-3 levels and risk profiles was evaluated by generalized linear regression model with adjustment for etiology. Galectin-3 plasma levels increased linearly in the three risk strata based on the REVEAL 2.0 score (from 16.0 ± 5.7 in low-risk to 22.4 ± 6.3 in intermediate-risk and in 26.9 ± 7.7 ng/mL in high-risk patients (p for trend < 0.001). Galectin-3 levels were significantly lower in low-risk patients defined according to the prognostic parameters of ESC/ERS Guidelines (delta between low-risk and intermediate/high-risk = -9.3, 95% CI -12.8 to -5.8, p < 0.001, p < 0.001). Additionally, galectin-3 levels were lower in the low-risk profile defined on the basis of the echocardiographic evaluation of right heart performance (delta between low-risk and intermediate-/high-risk = -6.3, 95% CI -9.9 to -2.7, p = 0.001). Galectin-3 plasma levels are directly associated with several risk profiles in PAH patients. The prognostic role of this biomarker in PAH is worthwhile to be explored in larger prospective studies.
Collapse
Affiliation(s)
- Laura Scelsi
- Division of Cardiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy; (L.S.); (B.M.); (L.M.); (A.T.); (A.G.); (L.O.V.)
| | - Stefano Ghio
- Division of Cardiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy; (L.S.); (B.M.); (L.M.); (A.T.); (A.G.); (L.O.V.)
- Correspondence: ; Tel.: +39-0382-503460; Fax: +39-0382-501361
| | - Benedetta Matrone
- Division of Cardiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy; (L.S.); (B.M.); (L.M.); (A.T.); (A.G.); (L.O.V.)
| | - Letizia Mannucci
- Division of Cardiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy; (L.S.); (B.M.); (L.M.); (A.T.); (A.G.); (L.O.V.)
| | - Catherine Klersy
- Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy;
| | - Serenella Valaperta
- Clinical Chemistry, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy;
| | - Annalisa Turco
- Division of Cardiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy; (L.S.); (B.M.); (L.M.); (A.T.); (A.G.); (L.O.V.)
| | - Alessandra Greco
- Division of Cardiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy; (L.S.); (B.M.); (L.M.); (A.T.); (A.G.); (L.O.V.)
| | - Giuseppe Derosa
- Dipartimento di Medicina Interna e Terapia Medica Università di Pavia, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy;
| | - Luigi Oltrona Visconti
- Division of Cardiology, Fondazione IRCCS Policlinico S.Matteo, 27100 Pavia, Italy; (L.S.); (B.M.); (L.M.); (A.T.); (A.G.); (L.O.V.)
| |
Collapse
|
2
|
Infante M, Allavena P, Garlanda C, Nebuloni M, Morenghi E, Rahal D, Roncalli M, Cavuto S, Pesce S, Monari M, Valaperta S, Montanelli A, Solomon D, Bottoni E, Errico V, Voulaz E, Bossi M, Chiesa G, Passera E, Mantovani A, Alloisio M. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients. Int J Cancer 2015; 138:983-91. [PMID: 26348770 DOI: 10.1002/ijc.29822] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2015] [Revised: 08/06/2015] [Accepted: 08/14/2015] [Indexed: 12/19/2022]
Abstract
There is a well-established link between inflammation and cancer of various organs, but little data are available on inflammation-associated markers of diagnostic and prognostic clinical utility in pulmonary malignancy. Blood samples were prospectively collected from 75 resectable lung cancer patients before surgery and in a cohort of 1,358 high-risk subjects. Serum levels of long pentraxin 3 (PTX3) were determined by high-sensitivity ELISA. PTX3 immunostaining was evaluated by immunohistochemistry in cancer tissue. Serum PTX3 levels in the high-risk population were not predictive of developing subsequent lung cancer or any other malignancy; however, serum PTX3 values in patients with lung cancer were significantly higher compared with cancer-free heavy smokers. With a cutoff of 4.5 ng/ml, specificity was 0.80, sensitivity 0.69, positive predictive value 0.15 and negative predictive value 0.98. The receiver operating curve (ROC) for serum PTX3 had an area under the curve (AUC) of 83.52%. Preoperative serum PTX3 levels in lung cancer patients did not correlate with patient outcome, but high interstitial expression of PTX3 in resected tumor specimens was a significant independent prognostic factor associated with shorter survival (p < 0.001). These results support the potential of serum PTX3 as a lung cancer biomarker in high-risk subjects. Furthermore, PTX3 immunohistochemistry findings support the role of local inflammatory mechanisms in determining clinical outcome and suggest that local expression of PTX3 may be of prognostic utility in lung cancer patients.
Collapse
Affiliation(s)
- Maurizio Infante
- Thoracic Surgery Department, Humanitas Research Hospital, Rozzano, Milano, Italy
| | | | | | - Manuela Nebuloni
- Department of Pathology, University of Milan, L. Sacco Hospital, Milano, Italy
| | - Emanuela Morenghi
- Biostatistical Unit, Humanitas Research Hospital, Rozzano, Milano, Italy
| | - Daoud Rahal
- Department of Pathology, Humanitas Research Hospital, Rozzano, Milano, Italy
| | - Massimo Roncalli
- Department of Pathology, Humanitas Research Hospital, Rozzano, Milano, Italy
| | - Silvio Cavuto
- Department of Infrastructure Research and Statistics, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | | | - Marta Monari
- Humanitas Research Center, Rozzano, Milano, Italy
| | - Serenella Valaperta
- Clinical Investigation Laboratory, Fondazione IRCCS Policlinico San Matteo Hospital, Pavia, Italy
| | | | - Daniel Solomon
- Department of General Surgery, Rabin Medical Center, Petah Tiqva, Israel
| | - Edoardo Bottoni
- Thoracic Surgery Department, Humanitas Research Hospital, Rozzano, Milano, Italy
| | - Valentina Errico
- Thoracic Surgery Department, Humanitas Research Hospital, Rozzano, Milano, Italy
| | - Emanuele Voulaz
- Thoracic Surgery Department, Humanitas Research Hospital, Rozzano, Milano, Italy
| | - Manuela Bossi
- Service de Chirurgie Digestive et Metabolique, Hôpital Jean Verdier, Bondy, France
| | - Giuseppe Chiesa
- Thoracic Surgery Department, Humanitas-Gavazzeni Hospital, Bergamo, Italy
| | - Eliseo Passera
- Thoracic Surgery Department, Humanitas-Gavazzeni Hospital, Bergamo, Italy
| | - Alberto Mantovani
- Humanitas Research Center, Rozzano, Milano, Italy.,Humanitas University, Rozzano, Milano, Italy
| | - Marco Alloisio
- Thoracic Surgery Department, Humanitas Research Hospital, Rozzano, Milano, Italy
| |
Collapse
|
3
|
Lo Iacono N, Blair HC, Poliani PL, Marrella V, Ficara F, Cassani B, Facchetti F, Fontana E, Guerrini MM, Traggiai E, Schena F, Paulis M, Mantero S, Inforzato A, Valaperta S, Pangrazio A, Crisafulli L, Maina V, Kostenuik P, Vezzoni P, Villa A, Sobacchi C. Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO. J Bone Miner Res 2012; 27:2501-10. [PMID: 22836362 DOI: 10.1002/jbmr.1712] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2012] [Revised: 06/15/2012] [Accepted: 07/03/2012] [Indexed: 01/16/2023]
Abstract
In the last decades the molecular basis of monogenic diseases has been largely unraveled, although their treatment has often remained unsatisfactory. Autosomal recessive osteopetrosis (ARO) belongs to the small group of genetic diseases that are usually treated with hematopoietic stem cell transplantation (HSCT). However, this approach is not effective in the recently identified form carrying mutations in the receptor activator of NF-κB ligand (RANKL) gene. In this subset, therapy replacement approach based on RANKL delivery has a strong rationale. Here we demonstrate that the systematic administration of RANKL for 1 month to Rankl(-/-) mice, which closely resemble the human disease, significantly improves the bone phenotype and has beneficial effects on bone marrow, spleen and thymus; major adverse effects arise only when mice are clearly overtreated. Overall, we provide evidence that the pharmacological administration of RANKL represents the appropriate treatment option for RANKL-deficient ARO patients, to be validated in a pilot clinical trial.
Collapse
Affiliation(s)
- Nadia Lo Iacono
- UOS/IRGB, Milan Unit, CNR, Milan, Italy; Humanitas Clinical and Research Center, Rozzano, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Alpini C, Lotzniker M, Valaperta S, Bottone MG, Malatesta M, Montanelli A, Merlini G. Characterization for anti-cytoplasmic antibodies specificity by morphological and molecular techniques. Auto Immun Highlights 2012; 3:79-85. [PMID: 26000130 PMCID: PMC4389067 DOI: 10.1007/s13317-012-0033-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/02/2012] [Accepted: 05/03/2012] [Indexed: 11/26/2022]
Abstract
PURPOSE The aim of our study was the characterization of anti-cytoplasmic antibodies by home-made morphological and biochemical techniques. Indeed, indirect immunofluorescence (IIF) on HEp-2 cell line is not always exhaustive in relation to the complexity of the antigens involved. METHODS Nine serum samples with anti-cytoplasmic antibodies (2 anti-Golgi apparatus, 3 with diffuse pattern and 4 with lysosome/endosome-like pattern) were tested with fluorescent confocal microscopy, Western blot analysis and, when necessary, with electron microscopy technique. RESULTS Confirmation of the IIF staining pattern was performed in confocal microscopy by comparison with the respective antibody marker. The anti-endoplasmatic reticulum positivity was also confirmed by electron microscopy evaluation. Both anti-lysosome/endosome and anti-endoplasmatic reticulum positivity have been definitely identified by Western blot through clear reactivity with calreticulin and LC3B, respectively. CONCLUSIONS These results do not aim at representing a standard routine laboratory procedure. Electron microscopy evaluation cannot be proposed as a routine approach, but confocal microscopy technique may be offered in centralized reference laboratories. Newer technologies, especially multiplex immunoassay, can also lead to an easier identification of these autoantibodies, without recurring to a home-made immunoblotting. Only with a complete characterization we will be able to define the clinical relevance of anti-cytoplasmic antibodies, which are still considered as "esoteric" and not as "diagnostic" antibodies.
Collapse
Affiliation(s)
- Claudia Alpini
- Servizio Analisi Chimico Cliniche Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
| | - Milvia Lotzniker
- Laboratorio Analisi A.O. Ospedale Civile di, Legnano, Milan Italy
| | - Serenella Valaperta
- Servizio Analisi Chimico Cliniche Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
| | - Maria Grazia Bottone
- Dipartimento di Biologia e Biotecnologie “L.Spallanzani”, Laboratorio di Biologia Cellulare e Neurobiologia, Università di Pavia, Pavia, Italy
- Istituto di Genetica Molecolare del CNR, Pavia, Italy
| | - Manuela Malatesta
- Dipartimento di Biologia e Biotecnologie “L.Spallanzani”, Laboratorio di Biologia Cellulare e Neurobiologia, Università di Pavia, Pavia, Italy
| | | | - Giampaolo Merlini
- Servizio Analisi Chimico Cliniche Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
| |
Collapse
|
5
|
Monari M, Valaperta S, Garbelli S, Montanelli A. 25-Hydroxyvitamin D levels in the outpatient population of a northern Italy region. Mediterranean Journal of Nutrition and Metabolism 2011. [DOI: 10.3233/s12349-011-0064-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Marta Monari
- Clinical Investigation Laboratories, IRCCS Istituto Clinico Humanitas, Via Manzoni, 56, 20089 Rozzano, Milan, Italy. e-mail:
| | - Serenella Valaperta
- Clinical Investigation Laboratories, IRCCS Istituto Clinico Humanitas, Via Manzoni, 56, 20089 Rozzano, Milan, Italy. e-mail:
| | - Stefano Garbelli
- Information Technology, IRCCS Istituto Clinico Humanitas, Via Manzoni, 56, 20089 Rozzano, Milan, Italy
| | - Alessandro Montanelli
- Clinical Investigation Laboratories, IRCCS Istituto Clinico Humanitas, Via Manzoni, 56, 20089 Rozzano, Milan, Italy. e-mail:
| |
Collapse
|
6
|
Monari M, Valaperta S, Montanelli A. [Parvovirus B19: unexpected epidemiology]. Minerva Ginecol 2011; 63:86. [PMID: 21311423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|
7
|
Valaperta S, Alpini C, Bottone MG, Monari M, Assandri R, Montanelli A. [Anti-Golgi antibodies: let me look around]. Recenti Prog Med 2011; 102:11-13. [PMID: 21516664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
The new biotechnologies will be available a large number of diagnostic datas.The study of clinical cases with antibodies-anti-Golgi provides an opportunity to discuss the role of traditional approach by indirect immunofluorescence investigation.The strong collaboration between clinician and laboratory is the only possibility for a real progress.
Collapse
Affiliation(s)
- Serenella Valaperta
- Laboratorio Analisi Cliniche, IRCCS Istituto Clinico Humanitas, Rozzano, Milano.
| | | | | | | | | | | |
Collapse
|
8
|
Monari M, Valaperta S, Baldassarre E, Assandri R, Montanelli A. HIV 1-2 Ag/Ab selective and combined detection by a new rapid point-of-care test. Microbiol Med 2010. [DOI: 10.4081/mm.2010.2412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
9
|
Zanier ER, Brandi G, Peri G, Longhi L, Zoerle T, Tettamanti M, Garlanda C, Sigurtà A, Valaperta S, Mantovani A, De Simoni MG, Stocchetti N. Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. Intensive Care Med 2010; 37:302-9. [PMID: 21072498 DOI: 10.1007/s00134-010-2075-2] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2010] [Accepted: 09/16/2010] [Indexed: 12/20/2022]
Abstract
PURPOSE To investigate plasma and cerebrospinal fluid (CSF) concentrations of pentraxin 3 (PTX3), a prototypic long pentraxin protein induced by proinflammatory signals, in subarachnoid hemorrhage (SAH), and its relation with SAH-associated vasospasm. METHODS Serial plasma and CSF samples were collected from 38 consecutive SAH patients admitted to the Neurosurgical Intensive Care. PTX3 concentrations were analyzed in relation to clinical status and clinical vasospasm (defined as neuro-worsening and angiographic confirmation of vessel narrowing). Since neutrophils are an important source of preformed PTX3, myeloperoxidase (MPO) in CSF was measured to assess the correlation with CSF PTX3 and establish whether blood contamination was the determinant of PTX3 increase. RESULTS PTX3 was elevated in all SAH patients both in plasma and CSF. Acute peak (first 48 h after SAH) CSF PTX3 was significantly higher in patients who later developed vasospasm [median 13.6 (range 2.3-51.9) ng/ml] compared to those who did not [3.2 (0.1-50.5) ng/ml, p = 0.03]. The temporal pattern of CSF PTX3 in patients with vasospasm was triphasic with a peak during the first 48 h after SAH, a subsequent decrease in the following 48-96 h and a secondary significant increase with the occurrence of vasospasm. A loose correlation between CSF PTX3 and MPO was observed (r(2) = 0.13), indicating that following SAH there is a brain production of PTX3. CONCLUSIONS Acute increased concentrations of PTX3 in CSF but not in plasma are related to the occurrence of vasospasm, indicating that measurement of CSF PTX3 associated with the clinical evaluation can improve early diagnosis of this complication.
Collapse
Affiliation(s)
- Elisa R Zanier
- Department of Neuroscience, Laboratory of Inflammation and Nervous System Diseases, Mario Negri Institute for Pharmacological Research, via Giuseppe La Masa, 19, 20156 Milan, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Cosentino S, Donida BM, Marasco E, Del Favero E, Cantù L, Lombardi G, Colombini A, Iametti S, Valaperta S, Fiorilli A, Tettamanti G, Ferraretto A. Calcium ions enclosed in casein phosphopeptide aggregates are directly involved in the mineral uptake by differentiated HT-29 cells. Int Dairy J 2010. [DOI: 10.1016/j.idairyj.2010.06.002] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Monari M, Valaperta S, Assandri R, Montanelli A. Diagnostic accuracy of a new commercially available HCV-antigen test. Microbiol Med 2010. [DOI: 10.4081/mm.2010.2488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
12
|
Mineri R, Ghilardi G, Brambilla S, Sarno T, Bologna M, Valaperta S, Montanelli A. The genetic variant of lactase persistence C/T (13910) and blood glucose control in type 1 diabetes mellitus patients. Mediterranean Journal of Nutrition and Metabolism 2009. [DOI: 10.3233/s12349-008-0027-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Rossana Mineri
- IRCCS, Istituto Clinico Humanitas, Clinical Investigation Laboratories, Via Manzoni, 20089 Rozzano (MI), Italy. e-mail:
| | - Giosuè Ghilardi
- Diabetology and Endocrinology Unit, Ospedale S. Biagio di Clusone, A.O. Bolognini, Seriate (BG), Italy
| | - Simona Brambilla
- IRCCS, Istituto Clinico Humanitas, Clinical Investigation Laboratories, Via Manzoni, 20089 Rozzano (MI), Italy. e-mail:
| | - Tiziana Sarno
- IRCCS, Istituto Clinico Humanitas, Clinical Investigation Laboratories, Via Manzoni, 20089 Rozzano (MI), Italy. e-mail:
| | - Muriel Bologna
- IRCCS, Istituto Clinico Humanitas, Clinical Investigation Laboratories, Via Manzoni, 20089 Rozzano (MI), Italy. e-mail:
| | - Serenella Valaperta
- IRCCS, Istituto Clinico Humanitas, Clinical Investigation Laboratories, Via Manzoni, 20089 Rozzano (MI), Italy. e-mail:
| | - Alessandro Montanelli
- IRCCS, Istituto Clinico Humanitas, Clinical Investigation Laboratories, Via Manzoni, 20089 Rozzano (MI), Italy. e-mail:
| |
Collapse
|
13
|
Mineri R, Ghilardi G, Brambilla S, Sarno T, Bologna M, Valaperta S, Montanelli A. The genetic variant of lactase persistence C/T (13910) and blood glucose control in type 1 diabetes mellitus patients. Mediterr J Nutr Metab 2009. [DOI: 10.1007/s12349-008-0027-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
Brambilla S, Valaperta S, Graziani G, Montanelli A. Gadolinium and lanthanum: A iatrogenic transmetallation? Clin Biochem 2008; 41:1029-33. [DOI: 10.1016/j.clinbiochem.2008.05.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2008] [Revised: 05/09/2008] [Accepted: 05/13/2008] [Indexed: 10/22/2022]
|